Seres Therapeutics Inc
(MCRB)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2015 | 06-2015 | 03-2015 | 12-2014 | 09-2014 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -35,146 | -20,526 | -7,971 | -16,700 | -8,527 |
| Depreciation Amortization | 394 | 212 | 92 | 190 | 113 |
| Accounts payable and accrued liabilities | 532 | -141 | -189 | 810 | 519 |
| Other Working Capital | -1,706 | -2,230 | -1,605 | 2,270 | 586 |
| Other Operating Activity | 6,651 | 4,689 | 1,333 | 3,080 | 1,066 |
| Operating Cash Flow | $-29,275 | $-17,996 | $-8,340 | $-10,350 | $-6,243 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -3,126 | -1,649 | -214 | -1,000 | -627 |
| Purchase Of Investment | -197,100 | -64,250 | -59,255 | N/A | 0 |
| Sale Of Investment | 47,295 | 8,725 | N/A | N/A | 0 |
| Other Investing Activity | 0 | 0 | 0 | -100 | -102 |
| Investing Cash Flow | $-152,931 | $-57,174 | $-59,469 | $-1,100 | $-729 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | 2,000 | 2,000 |
| Debt Repayment | -2,600 | -600 | -300 | -400 | -100 |
| Common Stock Issued | 140,347 | -2,053 | -1,007 | -811 | -20 |
| Other Financing Activity | -24 | -24 | -24 | 123,201 | 10,558 |
| Financing Cash Flow | $137,723 | $-2,677 | $-1,331 | $123,990 | $12,438 |
| Beginning Cash Position | 114,185 | 114,185 | 114,185 | 1,650 | 1,654 |
| End Cash Position | 69,702 | 36,338 | 45,045 | 114,180 | 7,120 |
| Net Cash Flow | $-44,483 | $-77,847 | $-69,140 | $112,530 | $5,466 |
| Free Cash Flow | |||||
| Operating Cash Flow | -29,275 | -17,996 | -8,340 | -10,350 | -6,243 |
| Capital Expenditure | -3,126 | -1,649 | -214 | -1,001 | -627 |
| Free Cash Flow | -32,401 | -19,645 | -8,554 | -11,351 | -6,870 |